Reperfusion After Fibrinolytic Therapy (RAFT): An open-label, multi-centre, randomised controlled trial of bivalirudin versus heparin in rescue percutaneous coronary intervention.

Reperfusion After Fibrinolytic Therapy (RAFT): An open-label, multi-centre, randomised controlled trial of bivalirudin versus heparin in rescue percutaneous coronary intervention.

Mostrar otras versiones (1)

<h4>Background</h4>The safety and efficacy profile of bivalirudin has not been examined in a randomised controlled trial of patients undergoing rescue PCI.<h4>Objectives</h4>We conducted an open-label, multi-centre, randomised controlled trial to compare bivalirudin with hepa...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Amir Faour, Nicholas Collins, Trent Williams, Arshad Khan, Craig P Juergens, Sidney Lo, Darren L Walters, Derek P Chew, John K French
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/3da8d2a609f849eabf83cc2f6167f89e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Search Result 1
Reperfusion After Fibrinolytic Therapy (RAFT): An open-label, multi-centre, randomised controlled trial of bivalirudin versus heparin in rescue percutaneous coronary intervention
Enlace del recurso
article
Agregar a favoritos
Guardado en:
Mostrar todas las versiones(2)

Ejemplares similares